An Extension Study to Provide Oraxol to Patients Who Completed KX-ORAX-007

Status Terminated

Clinical Trial Summary

KX-ORAX-008 is an extension study of patients who completed KX-ORAX-007 without disease progression as defined by Response Evaluation Criteria in Solid Tumors (RECIST) v1.1 and who wish to continue Oraxol treatment.

Clinical Trial Description

This is a multicenter, open-label, extension study offering the option of further Oraxol treatment to breast cancer patients who have completed the KX-ORAX-007 Oraxol study with complete response (CR), partial response (PR), or stable disease (SD), and who wish to continue further Oraxol treatment. The study contains 3 periods: the Screening Period, the Treatment Period, and the Follow-up Period. A Final Visit will occur within 7 days of the last dose of study treatment. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04168957
Study type	Interventional
Source	Athenex, Inc.
Contact
Status	Terminated
Phase	Phase 1
Start date	October 25, 2017
Completion date	November 12, 2020

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02944604` - The Efficacy and Safety of PEG-rhG-CSF（Pegylated Recombinant Human Granulocyte Colony Stimulating Factor)in Patients With Breast Cancer Who Were Treated With Intensive Chemotherapy	Phase 4
Completed	`NCT03012152` - A Comparative Study Between Oncoplastic Breast Surgery and Standard Conservative Surgery:Margin Status and Patient Satisfaction	N/A
Recruiting	`NCT02967146` - Anti-adhesive Effect and Safety of a Mixed Solid of Poloxamer, Gelatin and Chitosan(Mediclore®) After Axillary Dissection for Breast Cancer	Phase 3
Completed	`NCT02958332` - Effects of a Videogame-based Program on Women With Lymphedema Secondary to Breast Cancer	N/A
Completed	`NCT03030677` - Establishing Technique for PECS2 Catheter Insertion	N/A
Completed	`NCT03165955` - A Clinical Study to Determine the Pharmacokinetics of Oraxol in Breast Cancer Patients	Phase 1
Completed	`NCT03066947` - SV-BR-1-GM in Metastatic or Locally Recurrent Breast Cancer	Phase 1/Phase 2
Recruiting	`NCT02992574` - Trial Evaluating Role of Post Mastectomy Radiotherapy in Women With Node Negative Early Breast Cancer	N/A
Completed	`NCT02964234` - Empowering Latinas to Obtain Breast Cancer Screenings	N/A
Completed	`NCT02996240` - Breast, Omega 3 Free Fatty Acid, Ph 0	N/A
Completed	`NCT03010371` - Presential Vs Online Group-based Psychosocial Treatment for Breast Cancer Survivors.	N/A
Completed	`NCT02209857` - The Symphony Triple A Study: Using Symphony in Treatment Decisions Concerning Adjuvant Systemic Therapy	N/A
Completed	`NCT03014076` - Immunotherapy Vaccine and Herceptin in Breast Cancer	Phase 1
Terminated	`NCT02975128` - Minimal Invasive Breast Cancer Excision Using the Breast Lesion Excision System Under Ultrasound Guidance	N/A
Active, not recruiting	`NCT03121248` - Outcome of 15 Versus 5 Fractions in Adjuvant Breast Radiotherapy in Women Over 65 Years	N/A
Active, not recruiting	`NCT02997384` - Feasibility of Breast Cancer Risk Evaluation in Women From the General Population	N/A
Completed	`NCT03012893` - Identification of C7; Evaluations of 2 Sonographic Methods Using a Transverse and a Sagittal Scan.	N/A
Completed	`NCT03023007` - Study Evaluating the Efficacy of Loco-regional Anaesthesia PECS on Chronic Pain of a Mastectomy	N/A
Completed	`NCT04993040` - A PK Study of Oraxol in Breast Cancer Patients	Phase 1
Completed	`NCT02992067` - CK19 Combined With Contrast-enhanced Ultrasound: a Prediction System on Axillary Lymph Node Metastasis in Breast Cancer